BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:05 PM
 | 
Apr 23, 2007
 |  BC Extra  |  Clinical News

Vectura's VR004 meets ED endpoint

Vectura (LSE:VEC) said all three doses of VR004 met the primary endpoint of significantly improved erectile performance from baseline vs. placebo in a...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >